• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有线粒体 DNA 缺失的诱导多能干细胞。

Induced pluripotent stem cells with a mitochondrial DNA deletion.

机构信息

Boston Children's Hospital, Boston, MA, USA.

出版信息

Stem Cells. 2013 Jul;31(7):1287-97. doi: 10.1002/stem.1354.

DOI:10.1002/stem.1354
PMID:23400930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3692613/
Abstract

In congenital mitochondrial DNA (mtDNA) disorders, a mixture of normal and mutated mtDNA (termed heteroplasmy) exists at varying levels in different tissues, which determines the severity and phenotypic expression of disease. Pearson marrow pancreas syndrome (PS) is a congenital bone marrow failure disorder caused by heteroplasmic deletions in mtDNA. The cause of the hematopoietic failure in PS is unknown, and adequate cellular and animal models are lacking. Induced pluripotent stem (iPS) cells are particularly amenable for studying mtDNA disorders, as cytoplasmic genetic material is retained during direct reprogramming. Here, we derive and characterize iPS cells from a patient with PS. Taking advantage of the tendency for heteroplasmy to change with cell passage, we isolated isogenic PS-iPS cells without detectable levels of deleted mtDNA. We found that PS-iPS cells carrying a high burden of deleted mtDNA displayed differences in growth, mitochondrial function, and hematopoietic phenotype when differentiated in vitro, compared to isogenic iPS cells without deleted mtDNA. Our results demonstrate that reprogramming somatic cells from patients with mtDNA disorders can yield pluripotent stem cells with varying burdens of heteroplasmy that might be useful in the study and treatment of mitochondrial diseases.

摘要

在先天性线粒体 DNA(mtDNA)疾病中,正常和突变的 mtDNA(称为异质性)以不同水平存在于不同的组织中,这决定了疾病的严重程度和表型表达。Pearson 骨髓胰腺综合征(PS)是一种由 mtDNA 异质性缺失引起的先天性骨髓衰竭疾病。PS 中造血衰竭的原因尚不清楚,并且缺乏足够的细胞和动物模型。诱导多能干细胞(iPS)特别适合研究 mtDNA 疾病,因为细胞质遗传物质在直接重编程过程中得以保留。在这里,我们从 PS 患者中获得并表征了 iPS 细胞。利用异质性随细胞传代而变化的趋势,我们分离出了具有可检测水平缺失 mtDNA 的同基因 PS-iPS 细胞。我们发现,与没有缺失 mtDNA 的同基因 iPS 细胞相比,携带大量缺失 mtDNA 的 PS-iPS 细胞在体外分化时,在生长、线粒体功能和造血表型方面存在差异。我们的结果表明,对 mtDNA 疾病患者的体细胞进行重编程可以产生具有不同异质性负担的多能干细胞,这可能有助于线粒体疾病的研究和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2fc/3692613/569ee7635cee/nihms-446780-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2fc/3692613/793c0a1bcdfe/nihms-446780-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2fc/3692613/cf3bb15891e9/nihms-446780-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2fc/3692613/b0cd42eb16e2/nihms-446780-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2fc/3692613/b42148d1b496/nihms-446780-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2fc/3692613/569ee7635cee/nihms-446780-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2fc/3692613/793c0a1bcdfe/nihms-446780-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2fc/3692613/cf3bb15891e9/nihms-446780-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2fc/3692613/b0cd42eb16e2/nihms-446780-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2fc/3692613/b42148d1b496/nihms-446780-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2fc/3692613/569ee7635cee/nihms-446780-f0005.jpg

相似文献

1
Induced pluripotent stem cells with a mitochondrial DNA deletion.具有线粒体 DNA 缺失的诱导多能干细胞。
Stem Cells. 2013 Jul;31(7):1287-97. doi: 10.1002/stem.1354.
2
An infant with Pearson syndrome: a rare cause of congenital sideroblastic anemia and bone marrow failure.一名患有皮尔逊综合征的婴儿:先天性铁粒幼细胞贫血和骨髓衰竭的罕见病因。
Blood. 2017 May 11;129(19):2710. doi: 10.1182/blood-2017-02-766881.
3
Sideroblastic anemia associated with multisystem mitochondrial disorders.伴有多系统线粒体疾病的铁幼粒细胞性难治性贫血。
Pediatr Blood Cancer. 2019 Apr;66(4):e27591. doi: 10.1002/pbc.27591. Epub 2018 Dec 26.
4
Pearson syndrome.皮尔逊综合征。
Expert Rev Hematol. 2018 Mar;11(3):239-246. doi: 10.1080/17474086.2018.1426454. Epub 2018 Jan 23.
5
Pearson syndrome in a Diamond-Blackfan anemia cohort.钻石黑范贫血队列中的皮尔逊综合征
Blood. 2014 Jul 17;124(3):312-3. doi: 10.1182/blood-2014-04-571687.
6
Mitochondrial DNA with a large-scale deletion causes two distinct mitochondrial disease phenotypes in mice.大片段缺失的线粒体 DNA 在小鼠中导致两种不同的线粒体疾病表型。
G3 (Bethesda). 2013 Sep 4;3(9):1545-52. doi: 10.1534/g3.113.007245.
7
Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia.疑似患有先天性纯红细胞再生障碍性贫血患者的皮尔逊骨髓胰腺综合征。
Blood. 2014 Jul 17;124(3):437-40. doi: 10.1182/blood-2014-01-545830. Epub 2014 Apr 15.
8
Mitochondrial single-stranded DNA binding protein novel de novo SSBP1 mutation in a child with single large-scale mtDNA deletion (SLSMD) clinically manifesting as Pearson, Kearns-Sayre, and Leigh syndromes.线粒体单链 DNA 结合蛋白新的从头 SSBP1 突变导致的单一大片段线粒体 DNA 缺失(SLSMD)患儿,临床表现为 Pearson、Kearns-Sayre 和 Leigh 综合征。
PLoS One. 2019 Sep 3;14(9):e0221829. doi: 10.1371/journal.pone.0221829. eCollection 2019.
9
A novel mitochondrial DNA deletion in a patient with Pearson syndrome and neonatal diabetes mellitus provides insight into disease etiology, severity and progression.一名患有皮尔逊综合征和新生儿糖尿病的患者中发现的一种新型线粒体DNA缺失,为疾病的病因、严重程度和进展提供了线索。
Mitochondrial DNA A DNA Mapp Seq Anal. 2016 Jul;27(4):2492-5. doi: 10.3109/19401736.2015.1033712. Epub 2015 May 27.
10
Novel 5.712 kb mitochondrial DNA deletion in a patient with Pearson syndrome: a case report.一名患有皮尔逊综合征患者的新型5.712 kb线粒体DNA缺失:病例报告
Mol Med Rep. 2015 May;11(5):3741-5. doi: 10.3892/mmr.2014.3127. Epub 2014 Dec 22.

引用本文的文献

1
Optimization of mtDNA-targeted platinum TALENs for bi-directionally modifying heteroplasmy levels in patient-derived m.3243A>G-iPSCs.用于双向修饰患者来源的m.3243A>G诱导多能干细胞中异质性水平的线粒体DNA靶向铂类转录激活样效应因子核酸酶的优化
Mol Ther Nucleic Acids. 2025 Mar 19;36(2):102521. doi: 10.1016/j.omtn.2025.102521. eCollection 2025 Jun 10.
2
Engineering mtDNA deletions by reconstituting end joining in human mitochondria.通过重建人类线粒体中的末端连接来构建线粒体DNA缺失
Cell. 2025 May 15;188(10):2778-2793.e21. doi: 10.1016/j.cell.2025.02.009. Epub 2025 Mar 10.
3
Genetic analysis and multimodal imaging confirm m.12148 T > C mitochondrial variant pathogenicity leading to multisystem dysfunction.

本文引用的文献

1
UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells.UCP2 调节人多能干细胞的能量代谢和分化潜能。
EMBO J. 2011 Nov 15;30(24):4860-73. doi: 10.1038/emboj.2011.401.
2
The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming.诱导多能干细胞的代谢组学揭示了体细胞重编程过程中发生的代谢变化。
Cell Res. 2012 Jan;22(1):168-77. doi: 10.1038/cr.2011.177. Epub 2011 Nov 8.
3
Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming.
基因分析和多模态成像证实线粒体m.12148 T>C变异具有致病性,可导致多系统功能障碍。
Mol Genet Metab. 2025 Mar;144(3):109049. doi: 10.1016/j.ymgme.2025.109049. Epub 2025 Feb 7.
4
Brain organoid as a model to study the role of mitochondria in neurodevelopmental disorders: achievements and weaknesses.脑类器官作为研究线粒体在神经发育障碍中作用的模型:成就与不足
Front Cell Neurosci. 2024 Jun 24;18:1403734. doi: 10.3389/fncel.2024.1403734. eCollection 2024.
5
The NAD Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC derived Cortical Organoid of Alpers' Disease.烟酰胺核糖核苷酸作为 NAD 前体可挽救 Alpers 病诱导多能干细胞来源皮质类器官中的线粒体缺陷和神经元丢失。
Int J Biol Sci. 2024 Jan 25;20(4):1194-1217. doi: 10.7150/ijbs.91624. eCollection 2024.
6
Metabolic control of induced pluripotency.诱导多能性的代谢调控。
Front Cell Dev Biol. 2024 Jan 11;11:1328522. doi: 10.3389/fcell.2023.1328522. eCollection 2023.
7
Induced pluripotent stem cells derived from patients carrying mitochondrial mutations exhibit altered bioenergetics and aberrant differentiation potential.由携带线粒体突变的患者衍生的诱导多能干细胞表现出改变的生物能量学和异常的分化潜能。
Stem Cell Res Ther. 2023 Nov 7;14(1):320. doi: 10.1186/s13287-023-03546-7.
8
Induced pluripotent stem cells: ex vivo models for human diseases due to mitochondrial DNA mutations.诱导多能干细胞:源于线粒体 DNA 突变的人类疾病的体外模型。
J Biomed Sci. 2023 Sep 22;30(1):82. doi: 10.1186/s12929-023-00967-7.
9
The Mitochondrial m.3243A>G Mutation on the Dish, Lessons from In Vitro Models.线粒体 m.3243A>G 突变在体外模型中的启示。
Int J Mol Sci. 2023 Aug 30;24(17):13478. doi: 10.3390/ijms241713478.
10
Single-cell multi-omics of mitochondrial DNA disorders reveals dynamics of purifying selection across human immune cells.单细胞多组学分析线粒体 DNA 疾病揭示了人类免疫细胞中净化选择的动态变化。
Nat Genet. 2023 Jul;55(7):1198-1209. doi: 10.1038/s41588-023-01433-8. Epub 2023 Jun 29.
体细胞氧化生物能学转变为依赖多能性的糖酵解,以促进核重编程。
Cell Metab. 2011 Aug 3;14(2):264-71. doi: 10.1016/j.cmet.2011.06.011.
4
Energy metabolism in human pluripotent stem cells and their differentiated counterparts.人类多能干细胞及其分化细胞的能量代谢。
PLoS One. 2011;6(6):e20914. doi: 10.1371/journal.pone.0020914. Epub 2011 Jun 17.
5
The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.人诱导多能干细胞中衰老相关的线粒体/氧化应激途径受到抑制。
Stem Cells. 2010 Apr;28(4):721-33. doi: 10.1002/stem.404.
6
Isolated deficiencies of OXPHOS complexes I and IV are identified accurately and quickly by simple enzyme activity immunocapture assays.通过简单的酶活性免疫捕获测定法,可以准确快速地鉴定出氧化磷酸化复合体I和IV的孤立缺陷。
Biochim Biophys Acta. 2009 May;1787(5):533-8. doi: 10.1016/j.bbabio.2008.10.009. Epub 2008 Nov 10.
7
Formation and hematopoietic differentiation of human embryoid bodies by suspension and hanging drop cultures.通过悬浮培养和悬滴培养形成人胚状体及其造血分化
Curr Protoc Stem Cell Biol. 2007 Oct;Chapter 1:Unit 1D.2. doi: 10.1002/9780470151808.sc01d02s3.
8
Generation of human-induced pluripotent stem cells.人类诱导多能干细胞的产生。
Nat Protoc. 2008;3(7):1180-6. doi: 10.1038/nprot.2008.92.
9
Generation of human induced pluripotent stem cells from dermal fibroblasts.从真皮成纤维细胞生成人类诱导多能干细胞。
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2883-8. doi: 10.1073/pnas.0711983105. Epub 2008 Feb 15.
10
Selection against pathogenic mtDNA mutations in a stem cell population leads to the loss of the 3243A-->G mutation in blood.干细胞群体中针对致病性线粒体DNA突变的选择导致血液中3243A→G突变的缺失。
Am J Hum Genet. 2008 Feb;82(2):333-43. doi: 10.1016/j.ajhg.2007.10.007.